Search research articles
Contact Us
Filters
Showing results (41-50 of 297) with videos related to
Page
of 30
Sort By:
Current Opinion in Rheumatology
|
August 10, 2010
Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis
Jun Wei, Swati Bhattacharyya, John Varga
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 5, 2015
Editorial: genomic advances in systemic sclerosis: it is time for precision
John Varga, Elisha D O Roberson
Nature Reviews. Rheumatology
|
October 26, 2011
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya, Jun Wei, John Varga
Methods in Molecular Medicine
|
August 3, 2004
Animal models of scleroderma
Gabriella Lakos, Shinsuke Takagawa, John Varga
Current Rheumatology Reports
|
August 29, 2020
Calcinosis in Systemic Sclerosis: Updates in Pathophysiology, Evaluation, and Treatment
Carrie Richardson, Anna Plaas, John Varga
Current Opinion in Rheumatology
|
August 31, 2023
Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches
Alain Lescoat, Hiroshi Kato, John Varga
Current Opinion in Rheumatology
|
August 27, 2019
Calcinosis in scleroderma made crystal clear
Vivien Hsu, John Varga, Naomi Schlesinger
Seminars in Immunopathology
|
August 20, 2015
The immunopathology of systemic sclerosis
Jacob M van Laar, John Varga
Current Opinion in Rheumatology
|
September 10, 2021
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications
Alain Lescoat, Valérie Lecureur, John Varga
Current Opinion in Rheumatology
|
August 18, 2022
Role of cellular senescence in the pathogenesis of systemic sclerosis
Pei-Suen Tsou, Bo Shi, John Varga
Page
of 30
Search research articles
Search
Showing results (41-50 of 297) with videos related to
Sort By:
Page
of 30
Current Opinion in Rheumatology
|
August 10, 2010
Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis
Jun Wei, Swati Bhattacharyya, John Varga
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 5, 2015
Editorial: genomic advances in systemic sclerosis: it is time for precision
John Varga, Elisha D O Roberson
Nature Reviews. Rheumatology
|
October 26, 2011
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Swati Bhattacharyya, Jun Wei, John Varga
Methods in Molecular Medicine
|
August 3, 2004
Animal models of scleroderma
Gabriella Lakos, Shinsuke Takagawa, John Varga
Current Rheumatology Reports
|
August 29, 2020
Calcinosis in Systemic Sclerosis: Updates in Pathophysiology, Evaluation, and Treatment
Carrie Richardson, Anna Plaas, John Varga
Current Opinion in Rheumatology
|
August 31, 2023
Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches
Alain Lescoat, Hiroshi Kato, John Varga
Current Opinion in Rheumatology
|
August 27, 2019
Calcinosis in scleroderma made crystal clear
Vivien Hsu, John Varga, Naomi Schlesinger
Seminars in Immunopathology
|
August 20, 2015
The immunopathology of systemic sclerosis
Jacob M van Laar, John Varga
Current Opinion in Rheumatology
|
September 10, 2021
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications
Alain Lescoat, Valérie Lecureur, John Varga
Current Opinion in Rheumatology
|
August 18, 2022
Role of cellular senescence in the pathogenesis of systemic sclerosis
Pei-Suen Tsou, Bo Shi, John Varga
Page
of 30